Created at 12:06 p.m. Jan, 08, 2026
Author: lico3
Related Note: 1461794728973 1
Rationale for change

Interferon-α is for viral hepatitis, not for all types of hepatitis (e.g., APAP or EtOH toxicity)

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::02_Recombinant_cytokines_and_clinical_uses::02_Immunotherapy::*IFN-a #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::04_Immunology::01_Interferons #AK_Step2_v12::#SketchyIM::09_Infectious_Diseases::01_General_Conditions::02_Neutropenic_Fever_SOAP #AK_Step1_v12::^Systems::GI::pharm #AK_Other::Only_Step_1 #AK_Step1_v12::#Bootcamp::Microbiology::39_Antivirals::09_Hepatitis_B_Antiviral_Therapy #AK_Step1_v12::#OME::PreClinical::Immunology #AK_Step1_v12::#Physeo::09_Pharm::01_Immunology::09_Interferons_Alpha,_Beta,_&_Gamma #AK_Step1_v12::#Bootcamp::Microbiology::39_Antivirals::10_Hepatitis_C_Antiviral_Therapy #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::02_Recombinant_cytokines_and_clinical_uses #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology